Posted 2 months ago

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma

ClinicalTrials.gov ID NCT06246916

Protocol number R3767-ONC-22122

Sponsor Regeneron Pharmaceuticals, Inc.